Polaris Genomics’ Charles Cathlin shares how experiences at Ground Zero motivated him to launch our biotech startup that is dedicated to decoding the biological fingerprints of mental health. This PTSD Awareness Month and every day, we’re advancing discovery tools and diagnostics for PTSD and other mental health conditions in support of a range of populations, including veterans and active-duty US military service members, first responders, individuals in high-risk occupations, and trauma-exposed communities at large.
From Ground Zero to Genomics: Charles Cathlin’s Story
From Ground Zero to Genomics: Charles Cathlin’s Story
June 22, 2023
Press Contact
Jen Williams
jen@polarisgenomics.com
+1 802 355 5072
Additional Reading
Our Call to Serve: We’re Veterans Mapping the Biology of Mental Health
https://youtu.be/LoiE2KJtNoc On Veterans Day and always, we honor those who have served. As a veteran-owned business, our founding mission of improving the lives of service members and veterans remains at our roots. As a captain, Purple Heart recipient, 9/11...
Polaris Genomics Advances Mental Health Biomarker Discovery
For decades, psychiatry has struggled with a critical gap: unlike cardiology or oncology, there are no molecular biomarkers to guide diagnosis or treatment. Polaris Genomics was founded to change that, and our mission recently earned global recognition as we progress...
Conference Posters for Review
Our scientific team is often invited to present posters at a range of academic, pharma, and clinical research conferences focused on neuroscience and mental and brain health. If you have not been able to meet them in person and see our technical information firsthand,...
Notifications